Denali Therapeutics investor relations material
Listen to the latest call from Denali Therapeutics
Denali Therapeutics, Inc. is a biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company has been operating its business since 2013.
Ticker
DNLICountry
US